全外显子组测序识别回纹型风湿症的不同遗传特征
这项多中心前瞻性研究在中国10个风湿病中心纳入185例回纹型风湿症(PR)患者和272例健康对照,行全外显子组测序。按抗环瓜氨酸蛋白抗体(ACPA)20 IU/liter界值分层,ACPA+占27.02%、ACPA-占72.98%。研究识别出8个新位点和3个HLA等位基因与PR相关并超过全基因组显著性,多基因风险评分显示PR与类风湿关节炎(RA)不相似,而ACPA+与ACPA- PR间呈中等遗传相关。
要点
- ACPA+ PR占27.02%、ACPA- PR占72.98%,两组遗传背景不同。
- 识别8个新位点:ACPA-组ZNF503、RPS6KL1、HOMER3、HLA-DRA;ACPA+组RPS6KL1、TNPO2、WASH2P、FANK1,均P<5×10⁻⁸。
- 3个HLA等位基因:ACPA-组HLA-DRB1*0803和HLA-DQB1,ACPA+组HLA-DPA1*0401。
核心结论
- 本研究证明ACPA-与ACPA+ PR患者之间存在不同的遗传背景。
- 研究结果强化了PR与RA在遗传上不相似的认识。
研究设计与样本
- 多中心前瞻性研究,2015年9月至2020年1月在中国10个风湿病中心开展。
- 对185例PR患者和272例健康对照行全外显子组测序。
- 按ACPA滴度(界值20 IU/liter)将PR分为ACPA-和ACPA+亚组,行全外显子关联分析、HLA插补分型及多基因风险评分分析。
主要发现
- 185例PR中ACPA+ 50例(27.02%)、ACPA- 135例(72.98%)。
- 识别8个新位点:ACPA- PR组为ZNF503、RPS6KL1、HOMER3、HLA-DRA;ACPA+ PR组为RPS6KL1、TNPO2、WASH2P、FANK1,均超过全基因组显著性(P<5×10⁻⁸)。
- 识别3个HLA等位基因:ACPA- PR组为HLA-DRB1*0803和HLA-DQB1;ACPA+ PR组为HLA-DPA1*0401,均超过全基因组显著性(P<5×10⁻⁸)。
- 多基因风险评分显示PR与RA不相似(R²<0.025)。
- ACPA+ PR与ACPA- PR呈中等遗传相关(0.38<R²<0.8)。
关键数值与推荐
- ACPA阳性界值为20 IU/liter。
- 位点与HLA等位基因关联的全基因组显著性阈值为P<5×10⁻⁸。
- PR与RA遗传相似性为R²<0.025;ACPA+与ACPA- PR遗传相关为0.38<R²<0.8。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Previous studies have underlined the genetic susceptibility in the pathogenesis of palindromic rheumatism (PR), but the known PR loci only partially explain the disease's genetic background. We aimed to genetically identify PR by whole-exome sequencing (WES). METHODS: This multicenter prospective study was conducted in 10 Chinese specialized rheumatology centers between September 2015 and January 2020. WES was performed in 185 patients with PR and in 272 healthy controls. PR patients were divided into PR subgroups who were negative for anti-citrullinated protein antibody (ACPA-) and positive for ACPA (ACPA+) according to ACPA titer (cutoff value 20 IU/liter). We conducted whole-exome association analysis for the WES data. We used HLA imputation to type HLA genes. In addition, we used the polygenic risk score to measure the genetic correlations between PR and rheumatoid arthritis (RA) and the genetic correlations between ACPA- PR and ACPA+ PR. RESULTS: Among 185 patients with PR enrolled in our study, 50 patients (27.02%) were ACPA+ and 135 PR patients (72.98%) were ACPA-. We identified 8 novel loci (in the ACPA- PR group: ZNF503, RPS6KL1, HOMER3, HLA-DRA; in the ACPA+ PR group: RPS6KL1, TNPO2, WASH2P, FANK1) and 3 HLA alleles (in the ACPA- PR group: HLA-DRB1*0803 and HLA-DQB1; in the ACPA+ PR group: HLA-DPA1*0401) that were associated with PR and that surpassed genome-wide significance (P < 5 × 10-8 ). Furthermore, polygenic risk score analysis showed that PR and RA were not similar (R2 < 0.025), whereas ACPA+ PR and ACPA- PR showed a moderate genetic correlation (0.38 < R2 < 0.8). CONCLUSION: This study demonstrated the distinct genetic background between ACPA- and ACPA+ PR patients. Additionally, our findings strengthened that PR and RA were not genetically similar.
引用
- Zheng C, Wang F, Sun Y, et al. Identification of Distinct Genetic Profiles of Palindromic Rheumatism Using Whole-Exome Sequencing. Arthritis Rheumatol. 2023. PMID: 37219934. doi:10.1002/art.42614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。